Stuart Therapeutics, Inc. announces licensing agreement with Aju Pharm Co. Ltd. ...Middle East

STUART, Fla., Jan. 3, 2023 /PRNewswire/ -- Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement with AJU Pharm Co. Ltd. (hereinafter AJU), for Stuart's clinical stage drug candidate ST-100. Under this agreement, AJU has the exclusive right...

Hence then, the article about stuart therapeutics inc announces licensing agreement with aju pharm co ltd was published today ( Tuesday 03/01/2023 - 09:36 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Stuart Therapeutics, Inc. announces licensing agreement with Aju Pharm Co. Ltd. )

Also on site :

• GCE Global Solutions Corp. Announces Strategic Acquisition of GCE Payroll Advisers Inc. to Strengthen Global EOR and Payroll Platform
• Trump Wants To”Unleash Hell” In 2026; POTUS Tries To Go Full Maximus With A Misguided ‘Gladiator’ Flex
• Parents of Campbell Hall student killed in the school’s parking lot file wrongful death suit